EHMTI-0262. Dysregulation of inflammatory pathways in a familial hemiplegic migraine 1 mouse model after the induction of cortical spreading depression: Doc 760 von de Vries, B, Eising, Ee, Shyti, R, Vijfhuizen, Ls, Broos, Lam, Hoen, Pac't, Ferrari, Md, Tolner, Ea, van den Maagdenberg, Amjm

Volltext

P4.29 Differential tissue expression and decay of dystrophin mRNA and protein von Spitali, P, van Putten, M, Vossen, R.H, den Dunnen, J.T, van Ommen, G.J.B, t Hoen, P.A.C, Aartsma-Rus, A

Volltext

O.10 Effect of combined treatment with soluble activin receptor IIB and AAV-U7-mediated dystrophin exon skipping on muscle function in mdx mice von Hoogaars, W.M.H, Mouisel, E, Relizani, K, Pasternack, A, Hourde, C, Precigout, G, Ferry, A, Garcia, L, Kemaladewi, D.U, Aartsma-Rus, A, Ritvos, O, t Hoen, P.A.C, Amthor, H

Volltext

O.13 Interference of myostatin and TGF-beta signaling by antisense-mediated exon skipping in ALK4/5 receptors von Kemaladewi, D.U, van Heiningen, S.H, Aartsma-Rus, A, van Ommen, G.J.B, ten Dijke, P, t Hoen, P.A.C, Hoogaars, W.M.H

Volltext

P1.49 Mass spectrometry based clinical proteomics for biomarker discovery in Duchenne muscular dystrophy von Martin, F.C, Oonk, S, t Hoen, P.A.C, Nadarajah, V.D, Chaouch, A, Lochmüller, H, Dalebout, H, der Burgt, Y.E.M, Palmblad, M, Deelder, A.M

Volltext

P1.22 Low dystrophin levels improve life expectancy, phenotype and functional performance in the mdx/utrn -/- mouse von van Putten, M, Hulsker, M.A, van Heiningen, S.H, Nadarajah, V.D, Hoen, P.A.C. ’t, van Ommen, G.J.B, Aartsma-Rus, A.M

Volltext

P1.44 Development of heart failure in mice with low dystrophin levels von van der Pijl, E.M, van Putten, M, Nadarajah, V.D, van Opstal, A.M, Hulsker, M.A, t Hoen, P.A.C, van der Weerd, L, Aartsma-Rus, A.M

Volltext

P1.23 The effects of low dystrophin levels on muscle function and pathology von van Putten, M, Hulsker, M.A, van Heiningen, S.H, van Huizen, E, van Iterson, M, Admiraal, P, Messemaker, T, Dunnen, J.T. den, Nadarajah, V.D, t Hoen, P.A.C, Aartsma-Rus, A.M

Volltext

P1.48 Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring Duchenne muscular dystrophy (DMD) disease progression von t Hoen, P.A.C, Nadarajah, V.D, van Putten, M, Chaouch, A, Garrood, P, Straub, V, Ginjaar, H.B, Aartsma-Rus, A.M, van Ommen, G.J.B, Dunnen, J.T. den, Lochmüller, H

Volltext

P1.52 BIO-NMD: Discovery and validation of biomarkers for neuromuscular diseases (NMDs) – An EU funded FP7 project von Straub, V, Aartsma-Rus, A, Al-Khalili Szigyarto, C, Béroud, C, Bonaldo, P, Borgiani, P, Braghetta, P, Chaouch, A, Cirak, S, Courtot, L, Daraselia, N, Gelfi, C, Hoen, P.A.C. ’t, Kotelnikova, E, Le Priol, Y, Lochmueller, H, Morgan, J, Muntoni, F, Novelli, G, Paolillo, N, Tanzi, R, Turner, C, Uhlen, M, Ferlini, A

Volltext

EHMTI-0262. Dysregulation of inflammatory pathways in a familial hemiplegic migraine 1 mouse model after the induction of cortical spreading depression von de Vries, B, Eising, EE, Shyti, R, Vijfhuizen, LS, Broos, LAM, Hoen, PAC’t, Ferrari, MD, Tolner, EA, van den Maagdenberg, AMJM

Volltext

P2.44 Accelerated skeletal muscle ageing is a molecular signature in OPMD von Venema, A, Anvar, S.A, t’ Hoen, P.A.C, van der Sluijs, B, van Engelen, B, van der Maarel, S.M, Raz, V

Volltext

Design of a Targeted Peptide Nucleic Acid Prodrug To Inhibit Hepatic Human Microsomal Triglyceride Transfer Protein Expression in Hepatocytes von Biessen, Erik A. L, Sliedregt-Bol, Karen, 'T Hoen, Peter A. Chr, Prince, Perry, Van der Bilt, Erica, Valentijn, A. Rob P. M, Meeuwenoord, Nico J, Princen, Hans, Bijsterbosch, Martin K, Van der Marel, Gijs A, Van Boom, Jacques H, Van Berkel, Theo J. C

Volltext